
David M Rind MD
Assistant Clinical Professor of Medicine, Beth Israel Deaconess Medical
Join to View Full Profile
Beth Israel Deaconess Medical Center330 Brookline AvenueBoston, MA 02215
Phone+1 617-667-2700
Fax+1 617-667-6405
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Rind, MD is a board certified internist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is an Assistant Clinical Professor of Medicine at Beth Israel Deaconess Medical.
Education & Training
UMass Chan Medical SchoolResidency, Internal Medicine, 1986 - 1989
University of Rochester School of Medicine and DentistryClass of 1986
Certifications & Licensure
MA State Medical License 1987 - 2027
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsEvaluating the Cost-Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B Treatment in the USA.Jyotirmoy Sarker, Jeffrey A Tice, David M Rind, Surrey M Walton
Applied Health Economics and Health Policy. 2025-05-01 - 11 citationsA network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia.Abigail C Wright, Avery McKenna, Jeffrey A Tice, David M Rind, Foluso Agboola
Schizophrenia Research. 2024-12-01 - 2 citationsThe effectiveness and value of ensifentrine for the treatment of chronic obstructive pulmonary disease.Abigail C Wright, Grace A Lin, Melanie D Whittington, Avery McKenna, Finn Raymond
Journal of Managed Care & Specialty Pharmacy. 2024-11-01
Press Mentions
The Cost of Weight Loss Drugs Is Finally Dropping. How Low Can Prices Go?May 27th, 2025
Hope, Caution for Washington State Patients 'First in Line' for New Schizophrenia DrugApril 7th, 2025
How a Leftist Activist Group Helped Torpedo a Psychedelic TherapyFebruary 4th, 2025









